These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33665637)

  • 21. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
    Ryan CM; Schell TD
    J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
    Buseyne F; Rivière Y
    Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides.
    Besser H; Yunger S; Merhavi-Shoham E; Cohen CJ; Louzoun Y
    J Immunother Cancer; 2019 May; 7(1):135. PubMed ID: 31118084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.
    Jaigirdar A; Rosenberg SA; Parkhurst M
    J Immunother; 2016 Apr; 39(3):105-16. PubMed ID: 26938944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes.
    Dahal-Koirala S; Ciacchi L; Petersen J; Risnes LF; Neumann RS; Christophersen A; Lundin KEA; Reid HH; Qiao SW; Rossjohn J; Sollid LM
    J Biol Chem; 2019 Jan; 294(3):941-952. PubMed ID: 30455354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions.
    Bonomi G; Moschella F; Ombra MN; Del Pozzo G; Granier C; De Berardinis P; Guardiola J
    Hum Immunol; 2000 Aug; 61(8):753-63. PubMed ID: 10980386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.
    Manuel ER; Charini WA; Sen P; Peyerl FW; Kuroda MJ; Schmitz JE; Autissier P; Sheeter DA; Torbett BE; Letvin NL
    J Virol; 2006 Dec; 80(24):12032-40. PubMed ID: 17035327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors.
    Lee CH; Salio M; Napolitani G; Ogg G; Simmons A; Koohy H
    Front Immunol; 2020; 11():565096. PubMed ID: 33193332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!
    Gilchuk P; Hill TM; Wilson JT; Joyce S
    Curr Opin Immunol; 2015 Jun; 34():43-51. PubMed ID: 25660347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in glioblastoma proteins do not disrupt epitope presentation and recognition, maintaining a specific CD8 T cell immune response potential.
    Tarabini RF; Fioravanti Vieira G; Rigo MM; de Souza APD
    Sci Rep; 2024 Jul; 14(1):16721. PubMed ID: 39030304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
    Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
    Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs.
    Uemura Y; Senju S; Maenaka K; Iwai LK; Fujii S; Tabata H; Tsukamoto H; Hirata S; Chen YZ; Nishimura Y
    J Immunol; 2003 Jan; 170(2):947-60. PubMed ID: 12517961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.
    Berger CL; Longley J; Hanlon D; Girardi M; Edelson R
    Ann N Y Acad Sci; 2001 Sep; 941():106-22. PubMed ID: 11594564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.
    Simon P; Omokoko TA; Breitkreuz A; Hebich L; Kreiter S; Attig S; Konur A; Britten CM; Paret C; Dhaene K; Türeci Ö; Sahin U
    Cancer Immunol Res; 2014 Dec; 2(12):1230-44. PubMed ID: 25245536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells.
    Massafra V; Tundo S; Dietzig A; Ducret A; Jost C; Klein C; Kontermann RE; Knoetgen H; Steegmaier M; Romagnani A; Nagel YA
    J Immunol; 2021 Jul; 207(2):493-504. PubMed ID: 34215653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
    Pan K; Chiu Y; Huang E; Chen M; Wang J; Lai I; Singh S; Shaw RM; MacCoss MJ; Yee C
    Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34725257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.
    Shorter SK; Schnell FJ; McMaster SR; Pinelli DF; Andargachew R; Evavold BD
    PLoS One; 2016; 11(2):e0149582. PubMed ID: 26915099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.